Long-Term Safety and Tolerability of Canakinumab Prefilled Syringes in Frequently Flaring Acute Gouty Arthritis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

397

Participants

Timeline

Start Date

August 25, 2011

Primary Completion Date

May 9, 2013

Study Completion Date

May 9, 2013

Conditions
Acute Gouty Arthritis
Interventions
DRUG

Canakinumab 150mg in prefilled syringe

Canakinumab 150mg in prefilled syringe will be given in a single dose subcutaneously upon demand for gouty arthritis flares

Trial Locations (68)

10117

Novartis Investigative Site, Berlin

11042

Novartis Investigative Site, New Hyde Park

11501

Novartis Investigative Site, Mineola

11576

Novartis Investigative Site, Roslyn

16635

Novartis Investigative Site, Duncansville

23114

Novartis Investigative Site, Midlothian

23606

Novartis Investigative Site, Newport News

24541

Novartis Investigative Site, Danville

26826

Novartis Investigative Site, Weener

27401

Novartis Investigative Site, Greensboro

27518

Novartis Investigative Site, Cary

28144

Novartis Investigative Site, Salisbury

28152

Novartis Investigative Site, Shelby

28209

Novartis Investigative Site, Charlotte

28401

Novartis Investigative Site, Wilmington

28801

Novartis Investigative Site, Asheville

29204

Novartis Investigative Site, Columbia

29412

Novartis Investigative Site, Charleston

29651

Novartis Investigative Site, Greer

29707

Novartis Investigative Site, Fort Mill

29944

Novartis Investigative Site, Varnville

30035

Novartis Investigative Site, Decatur

30904

Novartis Investigative Site, Augusta

32584

Novartis Investigative Site, Löhne

33143

Novartis Investigative Site, South Miami

33458

Novartis Investigative Site, Jupiter

33773

Novartis Investigative Site, Largo

36547

Novartis Investigative Site, Gulf Shores

36608

Novartis Investigative Site, Mobile

37601

Novartis Investigative Site, Johnson City

37620

Novartis Investigative Site, Bristol

38125

Novartis Investigative Site, Memphis

39038

Novartis Investigative Site, Belzoni

39110

Novartis Investigative Site, Magdeburg

39209

Novartis Investigative Site, Jackson

39466

Novartis Investigative Site, Picayune

40217

Novartis Investigative Site, Louisville

42303

Novartis Investigative Site, Owensboro

44260

Novartis Investigative Site, Mogadore

48085

Novartis Investigative Site, Troy

51349

Novartis Investigative Site, Kaunas

58103

Novartis Investigative Site, Fargo

59804

Novartis Investigative Site, Missoula

66606

Novartis Investigative Site, Topeka

68114

Novartis Investigative Site, Omaha

68134

Novartis Investigative Site, Omaha

68516

Novartis Investigative Site, Lincoln

70006

Novartis Investigative Site, Metairie

75231

Novartis Investigative Site, Dallas

76021

Novartis Investigative Site, Bedford

77573

Novartis Investigative Site, League City

84010

Novartis Investigative Site, Bountiful

85224

Novartis Investigative Site, Chandler

85251

Novartis Investigative Site, Scottsdale

90620

Novartis Investigative Site, Buena Park

90650

Novartis Investigative Site, Norwalk

91361

Novartis Investigative Site, Westlake Village

93053

Novartis Investigative Site, Regensburg

98007

Novartis Investigative Site, Bellevue

36207-5710

Novartis Investigative Site, Anniston

A1A 5E8

Novartis Investigative Site, St. John's

A1E 2C2

Novartis Investigative Site, St. John's

G1V 3M7

Novartis Investigative Site, Sainte-Foy

LT-50128

Novartis Investigative Site, Kaunas

01117

Novartis Investigative Site, Vilnius

LT-92288

Novartis Investigative Site, Klaipėda

09310

Novartis Investigative Site, Vilnius

LT-08661

Novartis Investigative Site, Vilnius

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY